Patent ID: 8916537

Claim:
A method of treating cancer in a subject in need comprising administering to the subject a therapeutically effective dose of compound represented by the structure set forth in Formula (II) in which R 3 is selected from the group consisting of hydrogen, C 1 , C 2 , C 3 , C 4 , C 5 , C 6 , C 7 and C 8 linear and branched alkyl; L is selected from the group consisting of C 1 , C 2 , C 3 , C 4 , C 5 , C 6 , C 7 and C 8 linear, branched and cyclic alkyl, C 1 , C 2 , C 3 , C 4 , C 5 , C 6 , C 7 and C 8 linear, branched alkyl-amine, piperidinyl, aryl, and a combination thereof; U is selected from the group consisting of —O—; —(CO)O—; —O(CO)—NH—; and —(CO)—NH—; D is an anticancer drug; and pharmaceutically acceptable salts, hydrates, solvates and metal chelates of the compound.